Handelsbanken Fonder’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $427K | Hold |
13,500
| – | – | ﹤0.01% | 1309 |
|
|
2025
Q1 | $448K | Hold |
13,500
| – | – | ﹤0.01% | 1276 |
|
|
2024
Q4 | $465K | Buy |
13,500
+2,200
| +19% | +$75.8K | ﹤0.01% | 1319 |
|
|
2024
Q3 | $452K | Buy |
11,300
+1,500
| +15% | +$60K | ﹤0.01% | 1289 |
|
|
2024
Q2 | $296K | Buy |
9,800
+1,700
| +21% | +$51.3K | ﹤0.01% | 1389 |
|
|
2024
Q1 | $272K | Hold |
8,100
| – | – | ﹤0.01% | 1420 |
|
|
2023
Q4 | $262K | Hold |
8,100
| – | – | ﹤0.01% | 1432 |
|
|
2023
Q3 | $265K | Hold |
8,100
| – | – | ﹤0.01% | 1357 |
|
|
2023
Q2 | $285K | Hold |
8,100
| – | – | ﹤0.01% | 1368 |
|
|
2023
Q1 | $264K | Sell |
8,100
-120,000
| -94% | -$3.91M | ﹤0.01% | 1346 |
|
|
2022
Q4 | $7.06M | Buy |
128,100
+120,000
| +1,481% | +$6.61M | 0.04% | 372 |
|
|
2022
Q3 | $359K | Hold |
8,100
| – | – | ﹤0.01% | 1141 |
|
|
2022
Q2 | $395K | Hold |
8,100
| – | – | ﹤0.01% | 1162 |
|
|
2022
Q1 | $394K | Hold |
8,100
| – | – | ﹤0.01% | 1366 |
|
|
2021
Q4 | $345K | Buy |
+8,100
| New | +$345K | ﹤0.01% | 1562 |
|